Expert Pharmacovigilance & Drug Safety Analytics
Patient safety is at the heart of everything we do. Our pharmacovigilance services help pharmaceutical companies and regulators monitor, detect and assess adverse drug reactions using real-world data from both primary and secondary care, ensuring medicines remain safe for patients across the UK, USA and globally.
What We Do
- Adverse event detection and signal identification from real-world data
- Post-market safety surveillance using EHR, GP and hospital claims data
- Risk-benefit analysis and safety reporting
- Support for regulatory submissions (MHRA, EMA, FDA)
- Disproportionality analysis and data mining
- Integrate primary care prescribing data with secondary care outcomes for complete safety monitoring
Data Sources We Use
- GP prescribing and clinical records: primary care adverse event monitoring via EMIS, SystmOne and Vision
- Hospital Episode Statistics (HES): secondary care outcomes and adverse event identification
- Linked primary and secondary care data: connecting prescribing with outcomes for complete safety surveillance
- CPRD Aurum & Gold: gold-standard pharmacoepidemiology data
- US health data: for international drug safety studies
- Yellow Card and spontaneous reporting databases: regulatory signal detection
Who We Support
- Pharmaceutical and biotech companies
- Contract Research Organisations (CROs)
- Regulatory affairs teams
- Academic pharmacovigilance researchers
- US and international pharma partners
What You Get
- Signal detection reports
- Regulatory-grade safety documentation (MHRA, EMA, FDA)
- Risk management recommendations
- Publication-ready safety analyses
- Integrated primary and secondary care safety reports